PRME
Prime Medicine Inc.
$3.24
-$0.20(-5.81%)
61
Overall
--
Value
83
Tech
39
Quality
Market Cap
$488.50M
Volume
3.04M
52W Range
$1.11 - $5.17
Target Price
$6.50
Key Metrics Overview
| Market Cap | $488.50M | P/E Ratio | N/A |
| 52W High | $5.17 | 52W Low | $1.11 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 26.7% | 52W Position | 52.5% |
| Overall Score | 61 | Value Score | -- |
| Quality Score | 39 | Technical Score | 83 |
Growth Analysis
| EPS Current Est | $-1.23 | EPS Next Est | $-0.96 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRME | $3.24 | -5.8% | 3.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |